Table 1 Patient characteristics consisting elderly HNSCC patients treated by (chemo)radiotherapy in our institution between 2010 and 2018 (n = 246). Staging of HNSCC was based on the 7th Edition of the UICC TNM classification
n | % | ||
|---|---|---|---|
Sex | male | 170 | 69.1 |
female | 76 | 30.9 | |
Age | 65–74 years | 153 | 62.2 |
≥ 75 years | 93 | 37.8 | |
Smoking | non-smoker | 54 | 22.0 |
smoker | 142 | 57.7 | |
missing | 50 | 20.3 | |
Karnofsky | 100% | 28 | 11.4 |
90% | 108 | 43.9 | |
80% | 51 | 20.7 | |
70% | 23 | 9.3 | |
60% | 14 | 5.7 | |
50% | 3 | 1.2 | |
40% | 1 | 0.4 | |
missing | 18 | 7.3 | |
Localization | nasopharynx | 4 | 1.6 |
oropharynx | 79 | 32.1 | |
hypopharynx | 29 | 11.8 | |
oral cavity | 57 | 23.2 | |
larynx | 41 | 16.7 | |
parotid glands | 6 | 2.4 | |
other salivary glands | 3 | 1.2 | |
multi-level | 15 | 6.1 | |
others | 12 | 4.9 | |
T-stage | T1 | 35 | 14.2 |
T2 | 53 | 21.5 | |
T3 | 64 | 26.0 | |
T4 | 86 | 35.0 | |
N-stage | N0 | 82 | 33.3 |
N1 | 33 | 13.4 | |
N2 | 120 | 48.8 | |
N3 | 11 | 4.5 | |
M-stage | M0 | 232 | 94.3 |
M1 | 10 | 4.1 | |
UICC | I | 24 | 9.8 |
II | 20 | 8.1 | |
III | 48 | 19.5 | |
IVA/B | 145 | 58.9 | |
IVC | 9 | 3.7 | |
Grading | G1 | 6 | 2.4 |
G2 | 157 | 63.8 | |
G3 | 74 | 30.1 | |
G4 | 1 | 0.4 | |
HPV | HPV-negative | 49 | 19.9 |
HPV-positive | 34 | 13.8 | |
missing | 163 | 66.3 | |